PepsiCo Faces Pressure to Meet Elliott Targets
PepsiCo struggles to meet growth targets set after an activist stake as GLP-1 drugs threaten snack sales. Analysts await quarterly earnings to see if North American volumes and margins are recovering.
Xurve View
Insights:
Xurve View
PEPSICO INC faces a narrowing window to hit growth targets set after a $4B stake by Elliott Investment Management, amid pressures from GLP-1 weight-loss drugs. That pressure arrives as North American volumes contract under higher input costs linked to conflict in Iran and persistent inflation. Investors look to Thursday's quarterly report for proof that restructuring and pricing shifts can reverse sliding snack and beverage margins.
